Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis Read more about Intentional Self-Harm Following Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) Use in Patients with Diabetes: An Inverse Probability of Treatment Weighting Analysis
Duration of Follow Up for New Molecular Entities Approved in 2021: First Descriptive Analysis Read more about Duration of Follow Up for New Molecular Entities Approved in 2021: First Descriptive Analysis
Duration of Follow Up for New Molecular Entities Approved in 2020: First Descriptive Analysis Read more about Duration of Follow Up for New Molecular Entities Approved in 2020: First Descriptive Analysis
Duration of Follow Up for New Molecular Entities Approved in 2019: Second Descriptive Analysis Read more about Duration of Follow Up for New Molecular Entities Approved in 2019: Second Descriptive Analysis
Duration of Follow Up for New Molecular Entities Approved in 2018: Second Descriptive Analysis Read more about Duration of Follow Up for New Molecular Entities Approved in 2018: Second Descriptive Analysis
Prevalence of Selected Conditions Among Individuals with Childbearing Potential: A Descriptive Analysis Read more about Prevalence of Selected Conditions Among Individuals with Childbearing Potential: A Descriptive Analysis
Beta-Blocker-Associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database Read more about Beta-Blocker-Associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database
Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer Risk Read more about Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer Risk
Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy Read more about Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy
Counts and Characteristics of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor or Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor Users with Type 2 Diabetes: A Descriptive Analysis Read more about Counts and Characteristics of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor or Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor Users with Type 2 Diabetes: A Descriptive Analysis